24/7 Market News Snapshot 13 March, 2025 – Cardlytics, Inc. Common Stock (NASDAQ:CDLX)

March 13, 2025

DENVER, Colo., 13 March, 2025 (247marketnews.com) – (NASDAQ:CDLX) are discussed in this article.
Cardlytics, Inc. (CDLX) has experienced significant market fluctuations, opening at $2.22 this morning and currently trading at $2.171, reflecting a decline of approximately 9.65% from the previous closing price of $1.980. The trading volume has surged to 3.84 million shares, indicating heightened investor interest amid this volatility. Technical analysis points to a potential resistance level around the opening price, with support testing anticipated near $2.00. Investors are advised to monitor trading patterns closely, as a sustained increase in volume could signal either a recovery or further downside, highlighting the importance of risk management in this dynamic market.

In light of these developments, Faruqi & Faruqi, LLP, a well-regarded national securities law firm, has launched an investigation into potential claims against Cardlytics. The firm is actively reaching out to investors who have incurred losses exceeding $50,000 from March 14, 2024, to August 7, 2024, to explore their legal options. Allegations suggest that Cardlytics and its executives issued false or misleading statements and failed to disclose critical information that could have influenced investor decisions.

Concerns have been raised regarding the company’s reported increase in consumer engagement, which was not matched by proportional growth in billings, casting doubt on the sustainability of revenue. On May 8, 2024, Cardlytics disclosed an 8% year-over-year rise in first-quarter revenue, despite a 12% increase in billings, leading to a sharp stock value decline. Further compounding these issues, the company reported a 9% drop in second-quarter revenue on August 7, 2024, alongside leadership changes, including the resignation of the CEO, resulting in a staggering 57.1% drop in stock price.

Faruqi & Faruqi remains committed to advocating for affected investors and encourages potential lead plaintiffs to come forward. As the situation evolves, the firm emphasizes the necessity for vigilance and transparency in corporate governance, highlighting the critical rights of investors amidst these challenging developments.

Related news for (CDLX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.